Basic Information
| LncRNA/CircRNA Name | LINC00152 |
| Synonyms | CYTOR, C2orf59, LINC00152, NCRNA00152 |
| Region | GRCh38_2:87454781-87636740 |
| Ensemble | ENSG00000222041 |
| Refseq | NR_024204 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, Western blot |
| Sample | HCC tissues,cell lines(MHCC97,HB611) |
| Expression Pattern | up-regulated |
| Function Description | The expression of lncRNA 00152 in HCC tissues was significantly higher than that of matched para cancerous tissues and normal liver tissues. |
| Pubmed ID | 30779070 |
| Year | 2019 |
| Title | LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway. |
External Links
| Links for LINC00152 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |